日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Randomized Controlled Trial Evaluating Outcome Impact of Cilostazol in Patients with Coronary Artery Disease or at a High Risk of Cardiovascular Disease

一项评估西洛他唑对冠状动脉疾病患者或心血管疾病高危人群疗效的随机对照试验

Lin, Jia-Ling; Tseng, Wei-Kung; Lee, Po-Tseng; Lee, Cheng-Han; Tseng, Shih-Ya; Chen, Po-Wei; Chang, Hsien-Yuan; Chao, Ting-Hsing

Deletion of MicroRNA-21 Impairs Neovascularization Following Limb Ischemia: From Bedside to Bench

缺失microRNA-21会损害肢体缺血后的新生血管形成:从临床到基础研究

Chang, Wei-Ting; Lin, Yu-Wen; Huang, Po-Sen; Lin, You-Cheng; Tseng, Shih-Ya; Chao, Ting-Hsing; Chen, Zhih-Cherng; Shih, Jhih-Yuan; Hong, Chon-Seng

Effect of cilostazol on plasma levels of proprotein convertase subtilisin/kexin type 9.

西洛他唑对血浆中前蛋白转化酶枯草杆菌蛋白酶/kexin 9 型水平的影响

Chen I-Chih, Tseng Wei-Kung, Li Yi-Heng, Tseng Shih-Ya, Liu Ping-Yen, Chao Ting-Hsing

Cilostazol Improves Proangiogenesis Functions in Human Early Endothelial Progenitor Cells through the Stromal Cell-Derived Factor System and Hybrid Therapy Provides a Synergistic Effect In Vivo

西洛他唑通过基质细胞衍生因子系统改善人类早期内皮祖细胞的促血管生成功能,混合疗法在体内产生协同效应。

Tseng, Shih-Ya; Chao, Ting-Hsing; Li, Yi-Heng; Cho, Chung-Lung

Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial

常规冠状动脉造影对接受经皮腔内血管成形术的下肢动脉疾病患者的影响:一项多中心随机对照试验的研究方案

Chen, I-Chih; Lee, Cheng-Han; Chao, Ting-Hsing; Tseng, Wei-Kung; Lin, Tsung-Hsien; Chung, Wen-Jung; Li, Jen-Kwan; Huang, Hsuan-Li; Liu, Ping-Yen; Chao, Ting-Kuang; Chu, Chuin-Yuan; Lin, Chih-Chan; Hsu, Po-Chao; Lee, Wen-Huang; Lee, Po-Tseng; Li, Yi-Heng; Tseng, Shih-Ya; Tsai, Liang-Miin; Hwang, Juey-Jen